Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krim

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Immunology|November 1, 1985
Effect of interferon on chemiluminescence and hydroxyl radical production in murine macrophages stimulated by PMAM Ito, R Karmali, M Krim
Archives of Virology|January 1, 1984
Purification of human leukocyte interferon alpha by carboxymethyl controlled pore glass bead chromatographyI Mecs, D Chin, F Fox, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1982
Exogenous interferon administration in experimental leishmaniasis: in vivo and in vitro studiesD J Wyler, L F Liang, E Downey, et al.
Biochemical and Biophysical Research Communications|May 31, 1982
Interferon induction of polyamine-dependent protein kinase activity in Ehrlich ascites tumor cellsV Sekar, V J Atmar, M Krim, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1975
Identification of human RNA transcripts among heterogeneous nuclear RNA from man-mouse somatic cell hybridsR A Di Cioccio, R Voss, M Krim, et al.
Cancer Treatment Reports|March 1, 1986
Growth inhibition and eicosanoid metabolism in the R3230AC mammary adenocarcinoma by interferonR A Karmali, H Schellekens, F Lefevre, et al.
Biochemical and Biophysical Research Communications|August 12, 1983
Inhibition of ornithine decarboxylase in human fibroblast cells by type I and type II interferonsV Sekar, V J Atmar, A R Joshi, et al.
Scandinavian Journal of Immunology|October 1, 1985
Enhancement of cytotoxic activity of natural killer cells by interleukin 2, and antagonism between interleukin 2 and adenosine cyclic monophosphateM Chun, M Krim, A Granelli-Piperno, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Cytotoxic effector mechanisms in AIDSS Cunningham-Rundles, C E Metroka, B Safai, et al.
Cancer|April 15, 1986
Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factorsS E Krown, F X Real, S Vadhan-Raj, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Immunology|November 1, 1985
Effect of interferon on chemiluminescence and hydroxyl radical production in murine macrophages stimulated by PMAM Ito, R Karmali, M Krim
Archives of Virology|January 1, 1984
Purification of human leukocyte interferon alpha by carboxymethyl controlled pore glass bead chromatographyI Mecs, D Chin, F Fox, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1982
Exogenous interferon administration in experimental leishmaniasis: in vivo and in vitro studiesD J Wyler, L F Liang, E Downey, et al.
Biochemical and Biophysical Research Communications|May 31, 1982
Interferon induction of polyamine-dependent protein kinase activity in Ehrlich ascites tumor cellsV Sekar, V J Atmar, M Krim, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1975
Identification of human RNA transcripts among heterogeneous nuclear RNA from man-mouse somatic cell hybridsR A Di Cioccio, R Voss, M Krim, et al.
Cancer Treatment Reports|March 1, 1986
Growth inhibition and eicosanoid metabolism in the R3230AC mammary adenocarcinoma by interferonR A Karmali, H Schellekens, F Lefevre, et al.
Biochemical and Biophysical Research Communications|August 12, 1983
Inhibition of ornithine decarboxylase in human fibroblast cells by type I and type II interferonsV Sekar, V J Atmar, A R Joshi, et al.
Scandinavian Journal of Immunology|October 1, 1985
Enhancement of cytotoxic activity of natural killer cells by interleukin 2, and antagonism between interleukin 2 and adenosine cyclic monophosphateM Chun, M Krim, A Granelli-Piperno, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Cytotoxic effector mechanisms in AIDSS Cunningham-Rundles, C E Metroka, B Safai, et al.
Cancer|April 15, 1986
Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factorsS E Krown, F X Real, S Vadhan-Raj, et al.
Pageof 3